Low-dose thymoglobulin as second-line treatment for steroid-resistant acute GvHD: an analysis of the JSHCT.
Murata M, Ikegame K, Morishita Y, Ogawa H, Kaida K, Nakamae H, Ikeda T, Nishida T, Inoue M, Eto T, Kubo K, Sakura T, Mori T, Uchida N, Ashida T, Matsuhashi Y, Miyazaki Y, Ichinohe T, Atsuta Y, Teshima T.
Murata M, et al. Among authors: ashida t.
Bone Marrow Transplant. 2017 Feb;52(2):252-257. doi: 10.1038/bmt.2016.247. Epub 2016 Nov 21.
Bone Marrow Transplant. 2017.
PMID: 27869808
Clinical Trial.